Topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis

Zahi Touma, Lan Chen, Thurayya Arayssi

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Osteoarthritis is the most common degenerative joint disease and is particularly common in the elderly. Topical nonsteroidal anti-inflammatory drugs (NSAIDs) may represent a rational treatment in this situation because of their favorable side-effect profile. The majority of topical NSAIDs decrease pain and relieve functional disability caused by osteoarthritis over the short term, however, there are insufficient data for their long-term efficacy.

Original languageEnglish
Pages (from-to)163-175
Number of pages13
JournalFuture Rheumatology
Volume2
Issue number2
DOIs
Publication statusPublished - Apr 2007
Externally publishedYes

Fingerprint

Osteoarthritis
Anti-Inflammatory Agents
Pharmaceutical Preparations
Therapeutics
Pain

Keywords

  • Diclofenac
  • Ibuprofen
  • Ketoprofen
  • Meta-analysis
  • Osteoarthritis
  • Piroxicam
  • Randomized controlled trials
  • Topical nonsteroidal anti-inflammatory drugs

ASJC Scopus subject areas

  • Rheumatology

Cite this

Topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis. / Touma, Zahi; Chen, Lan; Arayssi, Thurayya.

In: Future Rheumatology, Vol. 2, No. 2, 04.2007, p. 163-175.

Research output: Contribution to journalReview article

@article{c63cad950c0f44e3ac2753758fe34255,
title = "Topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis",
abstract = "Osteoarthritis is the most common degenerative joint disease and is particularly common in the elderly. Topical nonsteroidal anti-inflammatory drugs (NSAIDs) may represent a rational treatment in this situation because of their favorable side-effect profile. The majority of topical NSAIDs decrease pain and relieve functional disability caused by osteoarthritis over the short term, however, there are insufficient data for their long-term efficacy.",
keywords = "Diclofenac, Ibuprofen, Ketoprofen, Meta-analysis, Osteoarthritis, Piroxicam, Randomized controlled trials, Topical nonsteroidal anti-inflammatory drugs",
author = "Zahi Touma and Lan Chen and Thurayya Arayssi",
year = "2007",
month = "4",
doi = "10.2217/17460816.2.2.163",
language = "English",
volume = "2",
pages = "163--175",
journal = "Future Rheumatology",
issn = "1758-4272",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis

AU - Touma, Zahi

AU - Chen, Lan

AU - Arayssi, Thurayya

PY - 2007/4

Y1 - 2007/4

N2 - Osteoarthritis is the most common degenerative joint disease and is particularly common in the elderly. Topical nonsteroidal anti-inflammatory drugs (NSAIDs) may represent a rational treatment in this situation because of their favorable side-effect profile. The majority of topical NSAIDs decrease pain and relieve functional disability caused by osteoarthritis over the short term, however, there are insufficient data for their long-term efficacy.

AB - Osteoarthritis is the most common degenerative joint disease and is particularly common in the elderly. Topical nonsteroidal anti-inflammatory drugs (NSAIDs) may represent a rational treatment in this situation because of their favorable side-effect profile. The majority of topical NSAIDs decrease pain and relieve functional disability caused by osteoarthritis over the short term, however, there are insufficient data for their long-term efficacy.

KW - Diclofenac

KW - Ibuprofen

KW - Ketoprofen

KW - Meta-analysis

KW - Osteoarthritis

KW - Piroxicam

KW - Randomized controlled trials

KW - Topical nonsteroidal anti-inflammatory drugs

UR - http://www.scopus.com/inward/record.url?scp=34249312648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249312648&partnerID=8YFLogxK

U2 - 10.2217/17460816.2.2.163

DO - 10.2217/17460816.2.2.163

M3 - Review article

AN - SCOPUS:34249312648

VL - 2

SP - 163

EP - 175

JO - Future Rheumatology

JF - Future Rheumatology

SN - 1758-4272

IS - 2

ER -